Sign in

meritxellnov.bsky.social

@meritxellnov.bsky.social
42 followers 52 following 0 posts

🧬 3D Genome and Epigenetics in Colorectal Cancer using CRISPR/Cas9-Engineered Organoid Models 👩🏼‍🔬👩🏼‍💻 Postdoctoral Researcher in MarciusLab at CNAG-CRG

PostsRepliesMedia
Reposted by @meritxellnov.bsky.social
The Batlle Lab @batllelab.bsky.social · 23/10/2025
🧵1/17 📣Thrilled to share our latest study just out in Cancer Discovery! ➡️ aacrjournals.org/cancerdiscov...
aacrjournals.org
A plastic EMP1⁺ to LGR5⁺ cell state conversion as a bypass to KRAS-G12D pharmacological inhibition in metastatic colorectal cancer
Abstract. Inhibitors of the oncogene KRAS hold promise for treating metastatic CRC (mCRC). Here we show that a selective, covalent small molecule inhibitor of the active (ON) conformation of RAS-G12D,...
14116
Reposted by @meritxellnov.bsky.social
Marc A. Marti-Renom @mamartirenom.bsky.social · 23/10/2025
Fantastic #Blutorial by our friends and colleagues at the @batllelab.bsky.social . We are so happy to collaborate with them. @meritxellnov.bsky.social and Mireia Novell in the lab have participated in this very important piece on metastatic colorectal cancer. 👏🏼👇🏼👇🏼👇🏼 aacrjournals.org/cancerdiscov...
aacrjournals.org
A plastic EMP1⁺ to LGR5⁺ cell state conversion as a bypass to KRAS-G12D pharmacological inhibition in metastatic colorectal cancer
Abstract. Inhibitors of the oncogene KRAS hold promise for treating metastatic CRC (mCRC). Here we show that a selective, covalent small molecule inhibitor of the active (ON) conformation of RAS-G12D,...
062